Pilocarpine

CAS 92-13-7 2 current records 5 historicalSmall Molecule

Who holds supplier records for Pilocarpine? 2 organisations hold a current record for Pilocarpine: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 2 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Brazil (2).

Most records are filed under another form of this substance: Pilocarpine Hydrochloride (4 current sources). A DMF or CEP is listed under the form it names.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Pilocarpine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/pilocarpine

Reading the evidence

  • 2 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in Brazil

    2 of the 2 current records with a recorded country list Brazil. Organisation country is not necessarily the manufacturing site.

  • No company-level GMP certificate matched

    No current EU or UK GMP certificate was matched to these organisations. That is not a negative finding; ask each candidate for its certificate and latest inspection outcome.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Pilocarpine expires 18 Aug 2037. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (2)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Pilocarpine. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Pilocarpine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (2)

Certificates of Suitability on the EDQM register for Pilocarpine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
ANIDRO DO BRASIL EXTRACOES S.A. ParnaibaBR
CEP 1999-006 - Rev 04
Pilocarpine nitrate
Aug 2026—
SOURCETECH QUIMICA LTDA. PindamonhangabaBR
CEP 2002-202 - Rev 05
Pilocarpine nitrate
Jul 2026—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (5)

Organisations whose Type II DMFs for Pilocarpine are no longer active. These show a past filing, not current supply.

Show all 5 historical records
  • STERLING WISCONSIN LLC
    Inactive DMF 16936 · filed Oct 2003
  • VEGEFLORA EXTRACOES DO NORDESTE LTDA
    Inactive DMF 12629, 9225 · filed Aug 1997
  • PVP SOCIEDADE ANONIMA
    Inactive DMF 11029 · filed Aug 1994
  • LINNEA PHYTOCHEMICALS
    Inactive DMF 7709 · filed Oct 1988
  • PLANTEX LTD CHEMICAL AND PHARMACEUTICAL WORKS
    Inactive DMF 4775 · filed Dec 1982

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (27 listed products contain Pilocarpine). The latest listed patent expires 18 Aug 2037. The latest listed exclusivity ended 17 Oct 2026. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Pilocarpine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL550).

Chemical identity

IUPAC name
(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one
Canonical SMILES
CC[C@H]1[C@H](COC1=O)CC2=CN=CN2C
InChIKey
QCHFTSOMWOSFHM-WPRPVWTQSA-N
Synonyms
Ocucarpine, Ocusert pilo, Ocusert pilo-20, Ocusert pilo-40, Pilocarpine, Pilocarpinum, Pilocarpol, Pilokarpin, Spersacarpine, Syncarpine, Pilocarpin, Ocusert P 20

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Pilocarpine?

2 organisations hold an active US FDA Type II Drug Master File or a CEP for Pilocarpine: ANIDRO DO BRASIL EXTRACOES SA (Brazil) and SOURCETECH QUIMICA LTDA (Brazil). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

What do the historical Pilocarpine records mean?

5 organisations have only inactive Type II DMFs for Pilocarpine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Pilocarpine have a European Certificate of Suitability?

Yes. 2 organisations hold a valid CEP for Pilocarpine on the EDQM register, including ANIDRO DO BRASIL EXTRACOES S.A. Parnaiba (BR) and SOURCETECH QUIMICA LTDA. Pindamonhangaba (BR). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Pilocarpine?

Yes. The latest patent listed for an approved US product containing Pilocarpine expires 18 Aug 2037, across 27 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Pilocarpine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Pilocarpine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.